If you or someone you care about has been diagnosed with idiopathic pulmonary fibrosis, you may have a range of emotions. It’s common for patients and loved ones to feel fear, anxiety, and sadness. Some people also feel helpless. Although treatment may decrease symptoms, there is currently no cure for pulmonary fibrosis. But research continues, which will one day hopefully lead … [Read more...]
Lung Pre-Transplant Evaluation Process: What to Expect
A lung transplant may be a treatment option for some people with idiopathic pulmonary fibrosis. Whether you qualify for a transplant depends on your age and co-morbidities, which means additional health problems you may have. Your ability to do what is required before and after the transplant is also considered. Candidates for transplants must be selected carefully. If you … [Read more...]
The FDA Cracks Down on Stem Cell Clinics
I have written on this topic many times. The FDA is providing further muscle behind my warning that you should avoid “Stem Cell Clinics”. In a landmark statement, FDA Commissioner Dr. Scott Gottlieb said the agency “will not allow deceitful actors to take advantage of vulnerable patients by purporting to have treatments or cures for serious diseases without any proof that … [Read more...]
Buyer Beware: Stem Cell Treatment for Pulmonary Fibrosis
We get a lot of questions from patients about the potential treatment of Idiopathic Pulmonary Fibrosis (IPF) through Stem Cell Therapy. You may have seen ads promising to cure just about anything with stem cell therapy. Because Pulmonary Fibrosis is a progressive lung disease, many patients are understandably anxious in seeking a cure or at least some benefit wherever they can … [Read more...]
Research Updates for Pulmonary Fibrosis – June 2017
Annual Meeting of the American Thoracic Society The annual meeting of the American Thoracic Society recently concluded. Some exciting new data from clinical trials was presented. OFEV (Nintedanib) A new analysis from the major clinical trials that have already been concluded showed that patients with IPF who received OFEV had a 36% chance of improving or having stable lung … [Read more...]